Literature DB >> 18257820

A case report of a pyogenic liver abscess caused by Fusobacterium nucleatum in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis.

Secundino Cigarrán1, Carmen Neches, José María Lamas, Gerardo García-Trio, Mario Alonso, Jesus Saavedra.   

Abstract

Pyogenic liver abscess (PLA) is a process with significant morbidity and mortality and is a rare complication in an aisled way in patients with autosomal dominant polycystic kidney disease (ADPKD). In addition to hepatic cyst infection, intracystic hemorrhage is another complication seen in ADPKD patients; however, the liver parenchyma itself remains normal. A PLA located in normal liver tissue in these kinds of patients has not been previously reported. Fusobacterium nucleatum is an anaerobic bacterium with rare involvement other than in periodontal infections. A 58-year-old Caucasian male, who was on hemodialysis treatment from July 2004 due to end-stage renal disease secondary to ADPKD, was admitted with fever, rigor, chills, weakness, and abdominal pain of 10 days duration. During that time, ciprofloxacin 500 mg, twice daily, gentamycin 80 mg/48 h, and vancomycin 1 g/week, were prescribed, but treatment was interrupted by hospitalization. Physical examination on admission revealed that the patient had a fever of 39.8 degrees C, pallor, chills, right upper quadrant abdominal pain, and hepatosplenomegaly. Abdominal ultrasound revealed a 5.3 cm diameter collection with irregular configuration located in the caudate lobe. Abdominal computed tomography (CT) showed a large multiloculated hepatic collection. The PLA was managed with antibiotics (metronidazole) and continuous catheter drainage (8Fr drainage catheters [Abocath-T, Abbott, Sligo, Ireland]) into the abscess. Fluid culture was positive for F. nucleatum. Complete remission was obtained after 12 days without complications. We describe a PLA by F. nucleatum, in a very rare location in an ADPKD patient undergoing hemodialysis without complicated cysts, managed with antibiotics and percutaneous drainage with satisfactory resolution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18257820     DOI: 10.1111/j.1744-9987.2007.00548.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  7 in total

1.  Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity.

Authors:  Yann Fardini; Xiaowei Wang; Stéphanie Témoin; Stanley Nithianantham; David Lee; Menachem Shoham; Yiping W Han
Journal:  Mol Microbiol       Date:  2011-11-15       Impact factor: 3.501

Review 2.  Fusobacterial liver abscess: a case report and review of the literature.

Authors:  Dilip Jayasimhan; Linus Wu; Paul Huggan
Journal:  BMC Infect Dis       Date:  2017-06-20       Impact factor: 3.090

Review 3.  Infectious Disease Risk in Dialysis Patients: A Transdisciplinary Approach.

Authors:  Caroline Lamarche; Ioan-Andrei Iliuta; Thomas Kitzler
Journal:  Can J Kidney Health Dis       Date:  2019-04-29

4.  Fusobacterium nucleatum causing a pyogenic liver abscess: a rare complication of periodontal disease that occurred during the COVID-19 pandemic.

Authors:  Laurence Collins; Tom Diamond
Journal:  BMJ Case Rep       Date:  2021-01-26

5.  A Case of Giant Hepatic Hydatid Cyst Infected with Morganella morganii and the Literature Review.

Authors:  Ismail Necati Hakyemez; Mustafa Sit; Gulali Aktas; Tekin Tas; Fırat Zafer Mengeloglu; Abdulkadir Kucukbayrak
Journal:  Case Rep Gastrointest Med       Date:  2012-11-11

6.  Peritoneal dialysis peritonitis by anaerobic pathogens: a retrospective case series.

Authors:  Chia-Ter Chao; Szu-Ying Lee; Wei-Shun Yang; Huei-Wen Chen; Cheng-Chung Fang; Chung-Jen Yen; Chih-Kang Chiang; Kuan-Yu Hung; Jenq-Wen Huang
Journal:  BMC Nephrol       Date:  2013-05-24       Impact factor: 2.388

7.  Epidemiology and mortality of liver abscess in end-stage renal disease dialysis patients: Taiwan national cohort study.

Authors:  Chon-Seng Hong; Kun-Ming Chung; Po-Chang Huang; Jhi-Joung Wang; Chun-Ming Yang; Chin-Chen Chu; Chung-Ching Chio; Fu-Lin Chang; Chih-Chiang Chien
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.